| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.003 |